UMMC Navigation

Children's Health

Main Content

Venous Thromboembolic Event

Study title

Randomized open label active controlled safety and extrapolated efficacy study in pediatric subjects requiring anticoagulation for the treatment of venous thromboembolic event

  • Principal Investigator: Dr. Mary Taylor

Purpose

This study will assess an experimental drug in children requiring anticoagulation for the treatment of venous thromboembolic event.

Who can participate

Those eligible to participate in this study include:

  • Patients¬†ages 3 months to 18 years old with a confirmed thrombus or embolus

For more information

  • Dana Lindsay
    University of Mississippi Medical Center
    2500 N. State St.
    Jackson, MS 39216
    (601) 815-9480
  • IRB Number: 2016-0254